dr. tagawa on next steps for taxanes in prostate cancer
Published 7 years ago • 124 plays • Length 1:32Download video MP4
Download video MP3
Similar videos
-
2:25
dr. tagawa on updated results of taxynergy trial in prostate cancer
-
1:40
dr. tagawa on targeting psma in prostate cancer
-
2:29
dr. tagawa on brca2 in patients with prostate cancer receiving psma-targeted radionuclide therapy
-
2:06
dr. tagawa on ctc in neuroendocrine-positive prostate cancer
-
1:21
scott tagawa, md, on promising psma products in development for prostate cancer treatment
-
1:49
dr. tagawa on preliminary data with 225ac-j591 in mcrpc
-
5:06
asco 2019: dr. tagawa highlights key prostate cancer data
-
58:31
audio version uronurse episode 106: new immunotherapy approaches for bladder cancer
-
1:18
dr. tagawa discusses radiotherapy in prostate cancer
-
4:13
scott tagawa, md, on the prostate cancer treatment pipeline
-
2:31
dr. tagawa on abiraterone and docetaxel in mcrpc
-
1:51
dr. tagawa on remaining questions with psma-targeted radionuclide therapy in mcrpc
-
2:08
scott tagawa md, considers next steps in the development of the psma-targeted alpha emitter in mcrpc
-
7:17
scott tagawa, md, on psma targeting in prostate cancer treatment
-
0:52
dr. rathkopf on investigative agents in prostate cancer
-
1:22
dr. abida on genetic testing for prostate cancer
-
1:03
dr. slovin on the role of immunotherapy for prostate cancer
-
1:47
dr. saad on apalutamide combination for castration-resistant prostate cancer
-
1:16
dr. kantoff on approaches for progressive prostate cancer following androgen blockade